Antitumor agents and process for producing the same

Details Antitumor agents and process for producing the same Antitumor agents and process for producing the same

2006-04-11

2006-04-11

Saeed, Kamal A. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C525S088000

Reexamination Certificate

active

07026488

ABSTRACT:
Anticancer agents which contain as the active ingredient, a heme oxygenase inhibitory metalloporphyrin derivatives which are conjugated with amphipathic or water-soluble polymers (in particular, Zn-protoporphyrin (ZnPP) conjugated with polyethylene glycol). Because of being conjugated to amphipathic or water-soluble polymers, such as polyethylene glycol, the active ingredient can be administered by intravenous injection and can exert a remarkable anticancer effect owing to tumor selective delivery.

REFERENCES:
patent: 5601802 (1997-02-01), Hemmi et al.
patent: 5622685 (1997-04-01), Sinn et al.
patent: 5849259 (1998-12-01), Hilger et al.
patent: 6362175 (2002-03-01), Vinogradov et al.
patent: 2002/0155999 (2002-10-01), Han
patent: 538228 (1993-04-01), None
patent: 2360785 (2001-10-01), None
patent: 91/18006 (1991-11-01), None
patent: WO 9529915 (1995-11-01), None
Sahoo, S.K., et al., “Pegylated Zinc Protoporphyrin: A Water-Soluble Heme Oxygenase Inhibitor with Tumor Targeting Capacity,” Bioconjugate Chemistry, vol. 13, pp. 1031-1038 (available on the World Wide Web Jul. 16, 2002).
Iida, K., et al., “Energy Transfer and Electron Transfer of Poly(ethylene glycol)-Linked Fluorinated Porphyrin Derivatives in Lipid Bilayers,” Langmuir, vol. 12, pp. 450-458 (1996).
Doi, K., “Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth,” Brit. J. Cancer, vol. 80(12), pp. 1945-1954 (1999).
Maines, M., “Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications,” FASEB J., vol. 2(10) pp. 2557-2568 (1988) at p. 2557, col. 2, lines 2-6 and 39-42.
Maines, M., “Zinc-protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat,” Biochimica et Biophysica Acta, vol. 673, vol. 673, pp. 339-350 (1981), in Abstract, lines 9-11.
Woehrle, D., et al., “Polymer-bound porphyrins and their precursors. 10. Syntheses and photoredox properties of water-soluble polymers with covalently bonded zinc tetraphenyl-porphyrin,” Die Makromolekulare Chemie, vol. 192, pp. 819-832 (1991).
Abòs, P. et al., “Polymer bound pyrrole compounds, IX . . . .mesoporphyrin IX covalently bound to a low molecular weight polyethylene glycol,” Journal of Photochemistry and Photobiology, vol. 41, pp. 53-58 (1997) at p. 53, col. 2, lines 4-12.
Awanda, A., “The pipeline of new anticancer agents for breast cancer treatment in 2003,” Critical Reviews in Oncology/Hematology, vol. 48, pp. 45-63 at p. 46, 2nd col., line 3.
Doi et al.; “Induction of Heme Oxygenase-1 by Nitric Oxide and Ischaemia in Experimental Solid Tumors and Implications for Tumor Growth”; Br. J. Cancer, 1999, vol. 80, No. 12, pp. 1945 to 1954.
Sahoo et al; “Pegylated Zinc Protoporphyrin: A Water-Soluble Heme Oxygenase Inhibitor with Tumor”, Targeting Capacity, Bioconjugate Chem., 2002, vol. 13, No. 5, pp. 1031 to 1038.
Journal of Chinese Pharmaceutics, vol. 30, No. 12 (1995), pp. 746-478 w/English Abstract.

Affiliated with

Also associated with

Rating

Antitumor agents and process for producing the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor agents and process for producing the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor agents and process for producing the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3568447